Maryka Quik - Concepedia

Author

Maryka Quik

Parkinson's Institute and Clinical Center

Also Known As

M QUIK, M Quik, M. QUIK, M. Quik, Maryka Quik

183

Publications

10.1K

Citations

H-Index

Concepts

All Affiliations

Parkinson's Institute and Clinical Center SRI International University of Utah McGill University Johns Hopkins University

About

Maryka Quik is an author at Parkinson's Institute and Clinical Center specializing in medicine, neuropharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	64	2.9K
2	Social Sciences	19	24	1.1K
3	Health Sciences	10	10	371
4	Engineering	1	1	32
5	Natural Sciences	1	1	10

Maryka Quik

111

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain Maryka Quik, Leslie L. Iversen, Stephen R. Bloom Biochemical Pharmacology NeuropeptidesNeurophysiologyOther PeptidesMedicinePhysiology	1978	188
Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization Maryka Quik, Yelena Polonskaya, Alison Gillespie, The Journal of Comparative Neurology	2000	171
Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model Donato A. Di Monte, Alison L. McCormack, Giselle M. Petzinger, Movement Disorders	2000	163
Chronic oral nicotine treatment protects against striatal degeneration in MPTP‐treated primates Maryka Quik, Neeraja Parameswaran, Sarah E. McCallum, Journal of Neurochemistry	2006	148
A role for the nicotinic α-bungarotoxin receptor in neurite outgrowth in PC12 cells J. Chan, Maryka Quik Neuroscience Pc12 CellsSignal TransductionNicotinePhysiologyReceptor (Biochemistry)	1993	137
Nicotine reduces levodopa‐induced dyskinesias in lesioned monkeys Maryka Quik, Heather I. Cox, Neeraja Parameswaran, Annals of Neurology	2007	131
Long-Term Nicotine Treatment Decreases Striatal α6* Nicotinic Acetylcholine Receptor Sites and Function in Mice Albert Lai, Neeraja Parameswaran, Mirium Khwaja, Molecular Pharmacology	2005	121
Continuous and Intermittent Nicotine Treatment Reduces l-3,4-Dihydroxyphenylalanine (l-DOPA)-Induced Dyskinesias in a Rat Model of Parkinson’s Disease Tanuja Bordia, Carla Cristian Campos, Luping Z. Huang, Journal of Pharmacology and Experimental Therapeutics	2008	118
Vulnerability of<sup>125</sup>I-α-Conotoxin MII Binding Sites to Nigrostriatal Damage in Monkey Maryka Quik, Yelena Polonskaya, Jennifer M. Kulak, Journal of Neuroscience ToxinologyNeurotransmitterSelective DopaminergicOxidative StressToxicology	2001	111
Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra Maryka Quik, P.C. Emson, Eileen M. Joyce Brain Research BiochemistryNeurophysiologyMedicineSynaptic TransmissionRat Substantia Nigra	1979	100

Page 1